With a mobile-first experience, caryrx crowdfunding has redefined the on-demand pharmacy. Patients can use the app to submit their prescriptions, chat with a pharmacist, and schedule free delivery of prescriptions the same day. The company is setting a new bar for the next generation of pharmacy services by putting the patient’s needs first. In a world where convenience is paramount, this new approach to the traditional pharmacy is transforming healthcare for today’s busy, demanding consumers.
CaryRx is Redefining
With free delivery, CaryRx is redefining the on-demand pharmacy experience. The tech-enabled on-demand pharmacy has its headquarters in California, but its free service allows its customers to access its services from anywhere in the world. It is available to customers in any city in the US. The company is dedicated to serving the health needs of its customers around the clock.
CARY RX
Based in California, CARY RX is a tech-enabled on-demand pharmacy that offers free onsite pickup and delivery. With its TECH STACK platform, customers can order any type of medication, and receive it the same day. The company has a free mobile app and offers free delivery, so no matter where you are, you can access the medications you need.
Crowdfunding Deals – CaryRx Crowdfunding Deals
CaryRx is a digital pharmacy that delivers prescriptions to patients in any city in the country. The startup does not rely on distribution networks to provide its service. It excels in its mobile platform, and the app is free and easy to use. Patients can simply log into their account and order their prescriptions on the go. With an estimated 99% customer retention rate and over 1,400 active users, CaryRx is well-positioned to take the industry by storm.
McKesson
The company receives all of its medication from McKesson, one of the largest pharmaceutical wholesalers in the world. Regardless of the volume of prescriptions, the company is capable of fulfilling them. In addition, it works with Postmates, the largest on-demand delivery platform, to provide its clients with a fast and convenient delivery experience. Both platforms offer CaryRx investors two distinct advantages. First, the platform lets the company focus on its core offering while Postmates handles the delivery and inventory management.
Advantage of Crowdfunding
Another big advantage of crowdfunding is the potential to scale a company. For instance, CaryRx is looking to raise $2.5 million for its next $1 billion product. While this is a small amount, it will provide enough cash to grow its business. Also, equity crowdfunding is a great way to help an established business scale. The company is able to attract a wide variety of investors, and it has been able to attract multiple investors in a short period of time.
Crunchbase Review of CaryRx Crowdfunding
CaryRx is an app that provides prescription drug delivery. The app lets users pick the pharmacy and medication that they need, confirm their copay and schedule delivery. Most insurance plans are accepted, including Medicare and Medicaid. In the DC and MD areas, it offers free same-day delivery. Currently, the company is backed by an angel investor and plans to expand into other markets in the near future.
CaryRx – Wefunder CrowdLustro
As the largest pharmacy franchisee in the D.C. area, CaryRx is a good fit for the Wefunder community. The company receives all its medications from McKesson, one of the world’s largest pharmaceutical wholesalers. This ensures that it can meet any volume requirement. The company also has a strategic partnership with Postmates, the world’s largest on-demand delivery service. This partnership allows the pharmacy to focus on its core services and helps it attract more customers.
CaryRx Mobile App
In addition to having a great mobile platform, CaryRx will be able to deliver prescriptions to any location, even small cities, allowing it to expand beyond its existing distribution network. As a result, the company won’t have to rely on a distribution network to reach the masses. It will also excel with its app, which is available for download free of charge. The app will help patients avoid double ordering and prescriptions from being lost or stolen.The CaryRx mobile app is easy to use and provides seamless ordering. Patients can simply click and place their orders through the app. The mobile platform is a distinct asset for the company. While the startup has a large number of potential customers, the company is still in its early stages and needs additional funding.
NowRx CEO Cary Breese Wants to Raise $73 Million Via Crowdfunding
NowRx, a provider of same-day prescription delivery and telehealth services, is looking to raise $73 million via equity crowdfunding. With the JOBS Act, crowdfunding is a wildly popular way for startups to raise money. NowRx has raised $20M so far, but CEO Cary Breese wants to raise a total of $100M. He hopes to use the money to accelerate the company’s technology roadmap and expansion.In addition to raising seed funding, NowRx has successfully raised $20 million via its SeedInvest platform, making it the largest securities offering ever. However, Breese isn’t anti-VC.
NowRx’s Founders
NowRx’s founders are optimistic about the company’s future prospects. While pharmacy has historically been immune to recessions, a pandemic that affects millions of people could trigger a recession. This is why the company’s CEO is not anti-VC. Before raising any capital, the company raised seed funding from small venture firms like Visary Capital and Ulu Ventures. If the business proves to be a success, Breese may look to traditional venture funding as well.
Breese isn’t Anti-VC
NowRx has been looking to raise money via a traditional venture capital model to help finance its rapid expansion plans. In addition to raising seed funding, NowRx has successfully raised $20 million via its SeedInvest platform, making it the largest securities offering ever. However, Breese isn’t anti-VC. In fact, his company has previously raised seed capital from smaller firms like Visary Capital and Igniter100. If NowRx wants to raise $73 million via a more traditional route, he might want to consider a more conventional funding option.
